Evaluation of Na v 1.8 as a therapeutic target for Pitt Hopkins Syndrome
Preprint
Abstract
Pitt Hopkins Syndrome (PTHS) is a rare syndromic form of autism spectrum disorder (ASD) caused by autosomal dominant mutations in the Transcription Factor 4 ( TCF4 ) gene. TCF4 is a basic helix-loop-helix transcription factor that is critical for neurodevelopment and brain function through its binding to cis-regulatory elements of target genes. One potential therapeutic strategy for PTHS is to identify dysregulated target genes and normalize their dysfunction. Here, we propose that SCN10A is an important target gene of TCF4 that is an applicable therapeutic approach for PTHS. Scn10a encodes the voltage-gated sodium channel Na v 1.8 and is consistently shown to be upregulated in PTHS mouse models. In this perspective, we review prior literature and present novel data that suggests inhibiting Na v 1.8 in PTHS mouse models is effective at normalizing neuron function, brain circuit activity and behavioral abnormalities and posit this therapeutic approach as a treatment for PTHS.Keywords
All Related Versions
- Published version: Molecular Psychiatry, 28 (1), 76.
This publication has 47 references indexed in Scilit:
- Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins SyndromePharmaceutical Research, 2019
- Molecular Mechanisms of Transcription Factor 4 in Pitt-Hopkins SyndromeCurrent Genetic Medicine Reports, 2017
- Biallelic SCN10A mutations in neuromuscular disease and epileptic encephalopathyAnnals of Clinical and Translational Neurology, 2016
- Successful use of acetazolamide for central apnea in a child with Pitt–Hopkins syndromeAmerican Journal of Medical Genetics Part A, 2015
- 263.4 kb deletion within the TCF4 gene consistent with Pitt–Hopkins syndrome, inherited from a mosaic parent with normal phenotypeEuropean Journal of Medical Genetics, 2013
- Functional analysis ofTCF4missense mutations that cause Pitt-Hopkins syndromeHuman Mutation, 2012
- Acetazolamide for severe apnea in Pitt-Hopkins syndromeAmerican Journal of Medical Genetics Part A, 2012
- Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: Clinical score and further delineation of the TCF4 mutational spectrumHuman Mutation, 2011
- The role of the TCF4 gene in the phenotype of individuals with 18q segmental deletionsHuman Genetics, 2011
- Neurologic and ocular phenotype in Pitt–Hopkins syndrome and a zebrafish modelHuman Genetics, 2011